SHARES PLUMMETS AFTER NOVO NORDISK DEAL FAILURE

Shares of HIMS experienced a dramatic decline today following the unexpected cancellation of its partnership with pharmaceutical giant Novo Nordisk. Investors responded negatively to the news, sending the company's stock price plummeting by nearly fifteen percent. The reason for the collapse of the partnership remains unclear, but industry analysts